{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use", "item": "https://www.patentleaderboard.com/patent/8735604"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use

Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use

US Patent 8735604 · Granted May 27, 2014

Estimated economic value: $108,716,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bax inhibitors and uses thereof2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Aldoketo reductase inhibitors and uses thereof2025
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflamm2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025
Inhibitors of GLI1 as therapeutic agents2025
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of med2024
Aldoketo reductase inhibitors and uses thereof2024
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antag2024
Cyclic polypeptides for PCSK9 inhibition2024
Pharmaceutical compounds for treatment of medical disorders2024